Today’s top gainers include the company AbbVie Inc. (NYSE:ABBV) which is in the industry Drug Manufacturers – Major, gaining 0.00% today. In the last week its performance is 2.68%, and 7.13% for the past quarter. Currently, AbbVie Inc., ABBV has a target price of 72.28, so today’s gain of 0.00% is a significant step towards its target price. The GAP today is therefore 0.00%.
AbbVie Inc. (NYSE:ABBV), has a market cap of 112.35 B, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 70.30%.
At the current price of 70.6, it has a dividend yield of 3.63%, and its target price is 72.28. This is with a profit margin of 24.10%, and total debt/equity of 7.39. AbbVie Inc. (NYSE:ABBV) has a P/E of 18.18, as well as a forward P/E of 10.89.
With a current EPS of 3.88, and a forecasted EPS growth for next year at 17.28%,AbbVie Inc. (NYSE:ABBV) has had a EPS growth for the past five years at 10.90%. For the next five years EPS growth is projected to be 14.45%.
Performance for the year is 16.89%. Since its IPO date on 01/02/2013, the total performance to date is 12.74%.
Volume today for AbbVie Inc. (NYSE:ABBV), is 0, while its average volume is 5523.45. Whilst the total gain today was 0.00%, it did have a day high of -0.27%.
Volatility for this week has been at 1.42%, and 1.28% for the month. The 52-week low for AbbVie Inc., ABBV has been 28.22%, while the 52-week-high has reached -0.27%.
Looking at its return of investments, which is 18.00%, and its return on assets is 9.50%. AbbVie Inc. (NYSE:ABBV) has an operating margin of 36.30%. With a sales growth of 9.70% quarter over quarter. Bearing in mind that AbbVie Inc., ABBV is in the sector Healthcare, its long-term debt/equity is 7.31, and has a current ratio of 1.8 and 1.6 for quick ratio.
So what is the value of AbbVie Inc.? Well its PEG is 1.26, and the P/S is 4.29, along with a P/B of 22.56. Meanwhile it has a p/cash of 17.98.